Intravenous line-related outcomes by antibiotic route for children hospitalized with pneumonia

Jillian M Cotter1, Angela Dunn2, Isabella Zaniletti3

  • 1Section of Hospital Medicine, Department of Pediatrics, Children's Hospital Colorado, University of Colorado, Aurora, Colorado, USA.

PubMed

Insights

Initial oral antibiotics for pediatric pneumonia reduce peripheral intravenous catheter (PIV) use and complications like infiltration/extravasation. This approach enhances patient experience and minimizes PIV-related harms.

Area of Science:

  • Pediatric hospital medicine
  • Infectious disease management
  • Patient safety

Background:

  • Peripheral intravenous catheters (PIVs) are common in hospitalized children.
  • PIV complications, such as infiltration and extravasation, can cause pain and morbidity.
  • Antibiotic administration route may influence PIV utilization and associated risks.

Purpose of the Study:

  • To compare PIV utilization and complication rates between children with pneumonia receiving initial oral versus intravenous antibiotics.
  • To assess the association between antibiotic route and PIV-related harms.

Main Methods:

  • Retrospective cohort study.
  • Involved 1035 children hospitalized with pneumonia across four sites (2014-2020).
  • Compared PIV outcomes using bivariable and multivariable regression analyses.

Main Results:

  • 65% of children received initial oral antibiotics; 59% had PIVs.
  • Children receiving IV antibiotics had significantly higher PIV placement rates (99%) compared to those on oral antibiotics (38%).
  • Infiltration/extravasation rates were lower in children on oral antibiotics (1%) versus IV antibiotics (9%), with lower odds for oral antibiotic group (OR: 0.39).

Conclusions:

  • Initial oral antibiotic therapy for pediatric pneumonia is associated with reduced PIV utilization.
  • Choosing oral antibiotics over IV antibiotics can significantly decrease the risk of PIV infiltration/extravasation.
  • Oral antibiotic initiation offers a strategy to improve pediatric patient experience and minimize PIV-related morbidity.

Related Concept Videos

Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
223
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
751
Routes of Drug Administration: Parenteral01:25

Routes of Drug Administration: Parenteral

The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
209
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
308
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
177